Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

计划入组 33 人 · 首次发布于 2011 年 6 月 22 日

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

首次发布于 2017 年 4 月 12 日

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

计划入组 16 人 · 首次发布于 2020 年 9 月 1 日

2-mercaptobenzothiazole

C₇H₅NS₂

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

Recursion's REC-4881 Shows Durable Polyp Reduction in Familial Adenomatous Polyposis Phase 2 Trial

Recursion to Present Updated Clinical Data from Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis

Pasithea's PAS-004 Outperforms FDA-Approved MEK Inhibitor in Preclinical IBD Study